{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:32:48Z","timestamp":1791059568772,"version":"4.1.0"},"reference-count":89,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T00:00:00Z","timestamp":1288051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reviews in Medical Virology"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>For more than 30 years the filoviruses, Marburg virus and Ebola virus, have been associated with periodic outbreaks of hemorrhagic fever that produce severe and often fatal disease. The filoviruses are endemic primarily in resource\u2010poor regions in Central Africa and are also potential agents of bioterrorism. Although no vaccines or antiviral drugs for Marburg or Ebola are currently available, remarkable progress has been made over the last decade in developing candidate preventive vaccines against filoviruses in nonhuman primate models. Due to the generally remote locations of filovirus outbreaks, a single\u2010injection vaccine is desirable. Among the prospective vaccines that have shown efficacy in nonhuman primate models of filoviral hemorrhagic fever, two candidates, one based on a replication\u2010defective adenovirus serotype 5 and the other on a recombinant VSV (rVSV), were shown to provide complete protection to nonhuman primates when administered as a single injection. The rVSV\u2010based vaccine has also shown utility when administered for postexposure prophylaxis against filovirus infections. A VSV\u2010based Ebola vaccine was recently used to manage a potential laboratory exposure. Copyright \u00a9 2010 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/rmv.661","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T13:15:28Z","timestamp":1279890928000},"page":"344-357","source":"Crossref","is-referenced-by-count":69,"title":["Prospects for immunisation against Marburg and Ebola viruses"],"prefix":"10.1002","volume":"20","author":[{"given":"Thomas W.","family":"Geisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Bausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,26]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"645","volume-title":"Virus Taxonomy: VIIIth Report of the International Committee on Taxonomy of Viruses","author":"Feldmann H","year":"2004"},{"key":"e_1_2_7_3_2","first-page":"1409","volume-title":"Fields Virology","author":"Sanchez A","year":"2006"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000212"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90925-7"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1172705"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9367"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/35046108"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01876"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1258"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00959-06"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030177"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00105-07"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/520583"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.082"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00431-07"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.7.4.417"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00561-09"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005547"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00467-09"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-01593-3_9"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-01593-3_19"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01718165"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/515386"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/514305"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00126-09"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/jcpa.2001.0503"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0805.010284"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/7422"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780021"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/520602"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(95)94839-T"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/514310"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.12.6408-6412.2002"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030009"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1656(95)00104-2"},{"key":"e_1_2_7_37_2","first-page":"109","article-title":"Relationship between the level of specific antibodies with disease outcome in Cercopithecus aethiops monkeys in experimental Marburg disease","volume":"42","author":"Agafonova OA","year":"1997","journal-title":"Vopr Virusol"},{"key":"e_1_2_7_38_2","first-page":"109","article-title":"Mechanisms of protective immune response in models of Marburg fever in monkeys","volume":"40","author":"Ignat'ev GM","year":"1995","journal-title":"Vopr Virusol"},{"key":"e_1_2_7_39_2","first-page":"82","article-title":"An evaluation of the possibility of Ebola fever specific prophylaxis in baboons (Papio hamadryas)","volume":"39","author":"Mikhailov VV","year":"1994","journal-title":"Vopr Virusol"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.18.9176-9185.2002"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.06.006"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.360"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.1.2.177"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2.3.445"},{"key":"e_1_2_7_45_2","unstructured":"HeveyM NegleyD StaleyA SchmaljohnA.Determination of vaccine components required for protecting cynomolgus macaques against genotypically divergent isolates of Marburg virus.20th Annual Meeting of the American Society for Virology. Madison Wisconsin USA Abstract No. W36\u20104 2001."},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00353-X"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00362-1"},{"key":"e_1_2_7_48_2","unstructured":"GeisbertT BaileyM GeisbertJ et al. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburgvirus in nonhuman primates submitted."},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/43977"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612003400551"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119149"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.6.1013"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.318.5853.1048"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072681"},{"key":"e_1_2_7_55_2","unstructured":"BaileyM.Adenovirus vectors for vaccinating against Ebola virus. inFilovirus Global Symposium Libreville Gabon 2008."},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.3723-3732.1999"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.23.10903-10910.2000"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00482-2"},{"key":"e_1_2_7_59_2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4049\/jimmunol.121.2.744","article-title":"Target antigens for H\u20102\u2010restricted vesicular stomatitis virus\u2010specific cytotoxic T cells","volume":"121","author":"Zinkernagel RM","year":"1978","journal-title":"J Immunol"},{"key":"e_1_2_7_60_2","first-page":"53","article-title":"Cell\u2010mediated immunity to vesicular stomatitis virus infections in mice","volume":"46","author":"Zinkernagel RM","year":"1978","journal-title":"Exp Cell Biol"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1996.0065"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1987.36.177"},{"key":"e_1_2_7_63_2","first-page":"77","article-title":"Isolation of vesicular stomatitis virus from a patient","volume":"11","author":"Gaidamovich S","year":"1966","journal-title":"Vopr Virusol"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1988.39.312"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68546-2"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030002"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00456-08"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1607.100159"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.10.026"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000225"},{"key":"e_1_2_7_71_2","first-page":"897","volume-title":"Diseases Transmitted from Animals to Man","author":"Tesh RB","year":"1975"},{"key":"e_1_2_7_72_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/br.16.3.179-204.1952","article-title":"The natural history of vesicular stomatitis","volume":"16","author":"Hanson RP","year":"1952","journal-title":"Bacteriol Rev"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1086\/520591"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1223"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.14.8039-8047.2003"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2005.03.012"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.15.6821-6831.2000"},{"key":"e_1_2_7_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000066244.31769.83"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.01.015"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.10.4855-4865.2002"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.14.7344-7351.2004"},{"key":"e_1_2_7_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-8244(03)00273-6"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2005.07.011"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009161"},{"key":"e_1_2_7_85_2","article-title":"The production of hemagluttinin\u2010based virus\u2010like particles in plants: a rapid, efficient and safe response to pandemic influenza","author":"D'Auost MA","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"e_1_2_7_86_2","first-page":"158","article-title":"Sustained immunogenicity and high efficacy against HPV 16\/18 related cervical neoplasia: long\u2010term follow up through 6.4 years in women vaccinated with Cervarix (GSK's HPV\u201016\/18 AS04 candidate vaccine)","volume":"109","author":"Harper D","year":"2008","journal-title":"Gynecol Oncol"},{"key":"e_1_2_7_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68439-0"},{"key":"e_1_2_7_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328334c0e1"},{"key":"e_1_2_7_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.23"},{"key":"e_1_2_7_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.01.152"}],"container-title":["Reviews in Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frmv.661","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frmv.661","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T05:35:57Z","timestamp":1700544957000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/rmv.661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,26]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1002\/rmv.661"],"URL":"https:\/\/doi.org\/10.1002\/rmv.661","archive":["Portico"],"relation":{},"ISSN":["1052-9276","1099-1654"],"issn-type":[{"value":"1052-9276","type":"print"},{"value":"1099-1654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,26]]}}}